DP
TEVA icon

Diadema Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Diadema Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-300,000
Closed -$6.68M – 151
2024
Q4 		$6.68M Buy
+300,000
New +$5.46M 2.86% 9

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Diadema Partners's TEVA Position: Q1 2025 in Review

Diadema Partners sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2025, closing a stake of 300,000 shares — an estimated $6.68M sold.

Diadema Partners first reported a position in TEVA in Q4 2024 and held it in 1 quarter. The position peaked at $6.68M in Q4 2024. 562 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Diadema Partners reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2025 after selling out during the quarter.
  • Diadema Partners sold 300,000 Teva Pharmaceutical Industries Limited shares in Q1 2025, an estimated $6.68M.
  • Diadema Partners first reported a position in Teva Pharmaceutical Industries Limited in Q4 2024 and held it in 1 quarter.
  • Diadema Partners's Teva Pharmaceutical Industries Limited position peaked at $6.68M in Q4 2024.
  • 562 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2025.

Based on Diadema Partners's 13F filing for Q1 2025, filed 15 May 2025.